certolizumab
ucb pharmaceuticals
['axspa', 'certolizumab']
 other issues include the 2013 fda advisory committee meeting expressing concerns about paucity understanding of natural hx of nr-axspa this is when certolizumab was not approved for nr-axspa #eular2023
@bu_bmc_rheum | @rheum_covid @spartan_updates @official_asas | @UWRheum @UWEpidemiology 2020 | @OHSUIMres 2017 | @UTMBhealth 2014 | @UTAustin 2010